Literature DB >> 24993969

Comparison of pharmacokinetics and metabolism of Pro-Gly-Pro-Leu administered intranasally and intravenously in the blood and brain of rats.

K V Shevchenko1, T V V'yunova, L A Andreeva, I Yu Nagaev, V P Shevchenko, N F Myasoedov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24993969     DOI： 10.1134/S1607672914030090

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  1 in total

1.  Evaluation of direct transport pathways of glycine receptor antagonists and an angiotensin antagonist from the nasal cavity to the central nervous system in the rat model.

Authors:  Stuart T Charlton; Joanne Whetstone; Susan T Fayinka; Kevin D Read; Lisbeth Illum; Stanley S Davis
Journal:  Pharm Res       Date:  2008-02-22       Impact factor: 4.200
  1 in total
  3 in total

1.  Penetration of thyroliberin in the blood and brain regions at intranasal or intravenous administration.

Authors:  K V Shevchenko; T V Vyunova; A S Radilov; L A Andreeva; I Yu Nagaev; V P Shevchenko; V R Rembovsky; N F Myasoedov
Journal:  Dokl Biochem Biophys       Date:  2016-01-05       Impact factor: 0.788

2.  The penetration of 5-oxo-Pro-Arg-Pro into the brain and the major metabolic pathways of this peptide in the rat brain and blood at the intranasal and intravenous administration.

Authors:  K V Shevchenko; I Yu Nagaev; V P Shevchenko; L A Andreeva; S I Shram; N F Myasoedov
Journal:  Dokl Biochem Biophys       Date:  2017-05-17       Impact factor: 0.788

3.  Synthesis of N-acyl derivatives of Pro-Gly-Pro-Leu peptide: Proteolytic stability in vitro and effects on mouse macrophage cells RAW264.7.

Authors:  K V Shevchenko; V V Bezuglov; M G Akimov; I Yu Nagaev; V P Shevchenko; N F Myasoedov
Journal:  Dokl Biochem Biophys       Date:  2017-11-04       Impact factor: 0.788
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.